Thelin

Showing 2 posts of 2 posts found.

Pfizer withdraws hypertension drug Thelin

December 14, 2010
Sales and Marketing PAH, Pfizer, Thelin, liver damage, liver toxicity, patient safety, pulmonary arterial hypertension, sitaxentan

Pfizer has suffered a blow to its drug development programme with the withdrawal of pulmonary arterial hypertension (PAH) brand Thelin …

Pfizer adds another product to its PAH franchise

May 14, 2010
Research and Development Ergonex, PAH, Pfizer, Thelin, revatio, terguride, viagra

Pfizer has signed an agreement to acquire terguride, a drug for pulmonary arterial hypertension (PAH) currently in phase II testing, …

The Gateway to Local Adoption Series

Latest content